Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Floretyrosine F 18 · Pixclara, TLX101-CDx

Radiopharmaceutical · Acts on Large Neutral Amino Acid Transporter 1 and 2 (LAT1/LAT2) (SLC7A5) · developed by Telix

Approved FDA, Sep 2026
TLX Developer
1 Registered trials

What is Floretyrosine F 18?

Floretyrosine F 18 is a fluorine-18 labeled tyrosine analog and PET tracer that is taken up through the large neutral amino acid transporters LAT1 and LAT2, which are highly expressed in glioma tissue. It is studied for imaging brain metastases to distinguish tumor progression from treatment-related changes.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Pixclara, TLX101-CDx
Drug type
Radiopharmaceutical
Targets
Large Neutral Amino Acid Transporter 1 and 2 (LAT1/LAT2) (SLC7A5)
Mechanism
Acts on Large Neutral Amino Acid Transporter 1 and 2 (LAT1/LAT2) (SLC7A5)
Therapy area
Oncology
Developer
Telix (TLX)
FDA status
Approved as Pixclara (September 11, 2026), NDA218592 · FDA label
UNII
1326R5J1IA

✅ FDA-approved uses

From the indications section of the FDA label (version of Oct 7, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07931261 Phase 3 Brain Metastasis Not yet recruiting TLX

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Brain MetastasisPseudoprogressionRadiation NecrosisTumor Progression

Other drugs acting on SLC7A5

More from Telix

Sources

Updated Nov 15, 2026. Something wrong or missing? Report it on the TLX page.

Follow TLX, the company behind Floretyrosine F 18

See TLX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

TLX catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.